close to approving two different drug regimens for treating ulcers caused by Helicobacter pylori

April 1996

The FDA is close to approving two different drug regimens for treating ulcers caused by Helicobacter pylori.

These will be the first drugs to get approved for this indication. This means that companies will be able to promote them for this use.

One regimen is dual therapy with Biaxin (clarithromycin) and Prilosec (omeprazole). (Biaxin 500 mg TID and Prilosec 40 mg/day for 2 weeks...followed by 2 more weeks of Prilosec 20 mg/day.)

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote